Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The Pittsburgh Sleep Quality Index (PSQI): A new instrument for psychiatric research and practice. Psychiatry Research, 28(2), 193-213.
Carney, C. E., Buysse, D. J., Ancoli-Israel, S., Edinger, J. D., Krystal, A. D., Lichstein, K.L., & Morin, C.M. (2012). The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep, 35(2), 287-302.
Dunn, K. E., Finan, P. H., Andrew Tompkins, D., & Strain, E. C. (2018). Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients. Addictive Behaviors, 76, 8–14.
https://doi.org/10.1016/j.addbeh.2017.07.016
Greenwald, M. K., Moses, T. E., & Roehrs, T. A. (2021). At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities. Translational Research, 234, 58-73.
Johns, M. W. (1991). A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep, 14(6), 540-5.
Langstengel, J., & Yaggi, H. K. (2022). Sleep deficiency and opioid use disorder: Trajectory, mechanisms, and interventions. Sleep Deficiency and Health, 43(2), e1-e14.
https://doi.org/10.1016/j.ccm.2022.05.001
Nordmann, S., Lions, C., Vilotitch, A., Michel, L., Mora, M., Spire, B., … & Carrieri, M. P. (2016). A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study). Psychopharmacology, 233(7), 1203-1213.
Substance Abuse Mental Health Services Administration (2021). TIP 63: Medications for opiate use disorder.
Stein, M. D., Herman, D. S., Bishop, S., Lassor, J. A., Weinstock, M., Anthony, J., & Anderson, B. J. (2004). Sleep disturbances among methadone maintained patients. Journal of Substance Abuse Treatment, 26(3), 175-180.
Wilkerson, A. K., & McRae-Clark, A. L. (2021). A review of sleep disturbance in adults prescribed medications for opioid use disorder: potential treatment targets for a highly prevalent, chronic problem. Sleep Medicine, 84, 142-153.